FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/21/2026
Back to search
Official data from USPTO
ESTEVE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
05/22/2026
Trademark type
Combined
Nice classes
1, 5, 42
Filing date
07/25/2023
Registration date
10/28/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/28/2025
Last transaction
05/22/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
85
Owner location
ES
Examiner
MESSICK, TABITHA LEE
Law office
L40
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized wording "ESTEVE" with the middle horizontal line in the first letter "E" formed by two parallel sinuous lines.
Holders and representatives
Holders
ESTEVE PHARMACEUTICALS, S.A.
Representatives
Todd A. Sullivan Hayes Soloway P.C.
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical products for use in industrysciencephotographyas well as in agriculturehorticulture and forestryexcept fungicidesherbicidesinsecticides and parasiticides; unprocessed artificial resinsunprocessed plastics; manures for soils; fire extinguishing compositions; tempering and soldering preparations; chemical products for preserving foodstuffs; adhesives for use in industry; chemical test paper; bacterial preparations other than for medical or veterinary use; cultures of microorganisms other than for medical or veterinary use
Class 5
Pharmaceuticalveterinary and sanitary products for the treatment and prevention of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; anti-inflammatoriesanalgesics; sanitary preparations for medical purposes; vaccines; dietetic foodstuffs and dietary supplements for humansboth adapted for medical use; food for babies; medical plastersmaterials for dressings being bandages for dressings; materials for filling teeth and dental impressions; disinfectants; fungicidesherbicides; starch for dietetic or pharmaceutical purposes; Tobacco-free cigarettes for smoking cessation purposes; caustic pencils; blood plasma; blood for medical use; leeches for medical use; adhesives for dentures; semen for artificial insemination; pharmaceutical preparations for use in treating headaches in the nature of applications in stick form for headache relief; nutritive substances for microorganisms for medical use
Class 42
Medical researchpharmaceutical research and scientific research services
Publications
History of USPTO decisions and trademark events.
31 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/06/2026
FIMP
FINAL DISPOSITION PROCESSED
05/06/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/28/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/28/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
10/28/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/09/2025
PUBO
PUBLISHED FOR OPPOSITION
09/09/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/03/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/09/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/04/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/04/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/04/2025
RFNT
REFUSAL PROCESSED BY IB
05/17/2025
ATRV
ATTORNEY REVIEW COMPLETED
05/13/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/30/2025
RFRR
REFUSAL PROCESSED BY MPU
04/30/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/30/2025
CNRT
NON-FINAL ACTION WRITTEN
04/29/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/26/2025
ATRV
ATTORNEY REVIEW COMPLETED
04/25/2025
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
04/16/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/08/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/08/2025
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
10/11/2024
CRSN
CORRECTION SENT TO IB
06/18/2024
CRCR
CORRECTION CREATED FOR IB
06/12/2024
DOCK
ASSIGNED TO EXAMINER
03/27/2024
MAFR
APPLICATION FILING RECEIPT MAILED
11/18/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/14/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/09/2023
Continuous trademark protection
Get notified about every new filing that threatens ESTEVE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.